This commentary is on the original article by Garone et al. To view this paper visit https://doi.org/10.1111/dmcn.14425

• Eight infants resistant to first‐line treatment were spasm‐free when treated with felbamate.
• No severe side effects were observed with a mean exposure time of 19 months.
• Mild, reversible neutropenia was experienced in 6 of 29 patients when felbamate was withdrawn.

• Tatton‐Brown‐Rahman syndrome is associated with intellectual disability and impaired adaptive functioning.
• Autistic traits were prevalent within the sample.
• Lower intellectual ability and adaptive behaviour were associated with greater severity of autistic traits.

This commentary is on the original article by Andrews et al. To view this paper visit https://doi.org/10.1111/dmcn.14401

• High‐quality prospective studies are needed to broaden the indication for fetal surgery in the general myelomeningocele population.
• Innovative minimally invasive approaches have had promising results, yet lack comprehensive and robust experimental or clinical evaluation.
• Important information to help families make informed decisions regarding fetal surgery for myelomeningocele is provided.